Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
KY100001
/
KPC Pharma
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
|||
|||||||
KY100001
/
KPC Pharma
New P1 trial, Metastases:
Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid Tumors
(clinicaltrials.gov) - May 27, 2021
P1
, N=109, Not yet recruiting,
Sponsor: Kunming Pharmaceuticals, Inc.